Research Articles | Page 16 | Aplastic Anemia & MDS International Foundation Return to top.

Research Articles

Compiled for your convenience are articles on bone marrow failure research and treatment from the world’s major journals on hematology / oncology.

Article Title Original Publication Date Journal Bone Marrow Disease
Is blood transfusion safe during the COVID-19 pandemic? Sep 2020 Future Science OA aplastic anemia, myelodysplastic syndromes (MDS), paroxysmal nocturnal hemoglobinuria (PNH)
Management of higher risk myelodysplastic syndromes after hypomethylating agents failure: are we about to exit the black hole? Sep 2020 Expert Review of Hematology myelodysplastic syndromes (MDS)
Novel therapeutic choices in immune aplastic anemia Sep 2020 F1000Research aplastic anemia
Patient preferences and quality of life implications of ravulizumab (every 8 weeks) and eculizumab (every 2 weeks) for the treatment of paroxysmal nocturnal hemoglobinuria. Sep 2020 PloS One paroxysmal nocturnal hemoglobinuria (PNH)
Clinical outcomes and characteristics of patients with TP53-mutated acute myeloid leukemia or myelodysplastic syndromes: a single center experience Sep 2020 Leukemia & Lymphoma acute myeloid leukemia (AML), myelodysplastic syndromes (MDS)
The Problem of TP53-Mutant MDS/AML Sep 2020 Clinical Lymphoma , Myeloma & Leukemia acute myeloid leukemia (AML), myelodysplastic syndromes (MDS)
New Approaches for Anemia in MDS Sep 2020 Clinical Lymphoma , Myeloma & Leukemia myelodysplastic syndromes (MDS)
Pitfalls in Assessing Response to Treatment in MDS Sep 2020 Clinical Lymphoma , Myeloma & Leukemia myelodysplastic syndromes (MDS)
The IPSS-R more accurately captures fatigue severity of newly diagnosed patients with myelodysplastic syndromes compared with the IPSS index Sep 2020 Leukemia myelodysplastic syndromes (MDS)
Content validity of patient-reported outcomes for use in lower-risk myelodysplastic syndromes Aug 2020 Journal of Patient-Reported Outcomes myelodysplastic syndromes (MDS)
Share with addtoany.com.